Sung-Yeon Im

Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea.

Part of Daewoong Co., Ltd., Daewoong Development Co., Ltd. is a pharmaceutical company based in Seoul, South Korea. The South Korean company focuses on creating better value for the healthy life of its customers through ceaseless research and development. Daewoong Development Co. provides a comfortable work space where employees can work flexibly and happily. The company also supports education on the local language and culture to help employees grow into talents. The CEO of the company is Jae-Chun Yoon.

Part of Daewoong Co., Ltd., Daewoong Development Co., Ltd. is a pharmaceutical company based in Seoul, South Korea. The South Korean company focuses on creating better value for the healthy life of its customers through ceaseless research and development. Daewoong Development Co. provides a comfortable work space where employees can work flexibly and happily. The company also supports education on the local language and culture to help employees grow into talents. The CEO of the company is Jae-Chun Yoon.

Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea.